Patients in the earliest stage of Alzheimer disease, with very mild symptoms, experienced the lowest risk of complications ...

Rural Georgians may find it difficult to access medication that could slow the progression of Alzheimer's disease, according ...

Rural Georgians may find it difficult to access medication that could slow the progression of Alzheimer's disease, according ...

Harley Street, a famous medical district in London, is an unusual place. It is highly successful, accounting for 40% of the ...

Cassidy’s comments come after Trump signed an executive order to make prescription drug prices in the United States ...

Adoption of lecanemab, a novel infusion treatment for Alzheimer’s disease (AD), has been disproportionately higher among ...

Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.

Until now, dementia diagnoses have often relied on questionnaires to indicate problems with memory as well as MRI scans to track loss of brain volume.

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

Aside from dubious efficacy data, Aduhelm has also been held back by the risk of side effects – known as amyloid-related imaging abnormalities (ARIA) – that were also more common with ...

Could something as simple as getting a shingles jab significantly reduce your risk of dementia? That's the intriguing ...